Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

1,124 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity ▴	Revenue growth	Diluted EPS
BBLG	Bone Biologics Corp Manufacturing · Year ended 2025-12-31 · USD	n/a	-$3.11M	n/a	-57.8%	n/a	-$2.65
CLIR	ClearSign Technologies Corp Manufacturing · Year ended 2025-12-31 · USD	$5.23M	-$5.50M	-105.0%	-57.7%	45.6%	-$0.99
AVIR	Atea Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$158.35M	n/a	-57.5%	n/a	-$1.94
VIR	Vir Biotechnology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$68.56M	-$437.99M	-638.9%	-57.2%	-7.6%	-$3.16
RXRX	Recursion Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$74.68M	-$644.76M	-863.4%	-57.0%	26.9%	-$1.44
TROO	Troops, Inc. /Cayman Islands Finance & Real Estate · Year ended 2025-12-31 · USD	$17.10M	-$27.91M	-163.2%	-56.9%	69.7%	-$0.23
ACON	Aclarion, Inc. Services · Year ended 2025-12-31 · USD	$75.7K	-$7.23M	n/m	-56.4%	65.6%	-$13.61
VKTX	Viking Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$359.64M	n/a	-56.3%	n/a	-$3.19
ELDN	Eledon Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$45.62M	n/a	-56.3%	n/a	-$0.52
IOVA	Iovance Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$263.50M	-$390.98M	-148.4%	-56.0%	60.6%	-$1.09
EMPD	Empery Digital Inc. Finance & Real Estate · Year ended 2025-12-31 · USD	$975.0K	-$150.05M	n/m	-55.7%	-75.5%	-$8.12
MGX	Metagenomi Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$25.21M	-$87.87M	-348.5%	-55.4%	-51.8%	-$2.36
DFTX	Definium Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$183.79M	n/a	-55.3%	n/a	-$2.06
DRTS	Alpha Tau Medical Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$42.63M	n/a	-55.3%	n/a	-$0.53
NEUP	Neuphoria Therapeutics Inc. Manufacturing · Year ended 2026-06-30 · USD	$1.17M	-$13.45M	n/m	-54.7%	-92.5%	-$3.06
RVSN	Rail Vision Ltd. Manufacturing · Year ended 2025-12-31 · USD	$1.49M	-$11.10M	-746.5%	-54.6%	14.4%	-$6.15
FEED	ENvue Medical, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.55M	-$18.18M	-712.3%	-54.3%	-0.2%	-$26.69
NEOV	NeoVolta Inc. Manufacturing · Year ended 2026-06-30 · USD	$13.33M	-$21.47M	-161.0%	-54.3%	58.2%	-$0.55
TENX	Tenax Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$52.60M	n/a	-54.2%	n/a	-$1.34
AVBP	ArriVent BioPharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$166.31M	n/a	-54.1%	n/a	-$4.32
AARD	Aardvark Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$57.59M	n/a	-54.0%	n/a	-$2.93
CGEM	Cullinan Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$219.88M	n/a	-53.8%	n/a	n/a
NNOX	Nano-X Imaging Ltd. Manufacturing · Year ended 2025-12-31 · USD	$13.02M	-$75.02M	-576.1%	-53.7%	15.4%	-$1.16
NGLD	Nevada Canyon Gold Corp. Mining · Year ended 2025-12-31 · USD	n/a	-$3.73M	n/a	-53.6%	n/a	$0.13
HAO	Haoxi Health Technology Ltd Services · Year ended 2026-06-30 · USD	$54.83M	-$9.54M	-17.4%	-53.4%	67.1%	-$386.40

Rows per page: 2550 100